ADC Therapeutics SA (ADCT)
Q2 2020 Earnings Conference Call
August 18, 2020, 08:30 ET
Company Participants
Amanda Hamilton - IR Officer
Christopher Martin - CEO & Director
Jay Feingold - Chief Medical Officer, Head, Oncology Clinical Development & Senior VP
Jennifer Creel - CFO
Conference Call Participants
Tazeen Ahmad - Bank of America Merrill Lynch
Matthew Harrison - Morgan Stanley
Boris Peaker - Cowen and Company
Presentation
Operator
Ladies and gentlemen, welcome to the ADC Therapeutics Q2 Earnings Call. [Operator Instructions].
At this point, I'll hand it over to the speaker. Please begin your meeting.